BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35764349)

  • 1. Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique.
    Thompson EF; Hoang L; Höhn AK; Palicelli A; Talia KL; Tchrakian N; Senz J; Rusike R; Jordan S; Jamieson A; Huvila J; McAlpine JN; Gilks CB; Höckel M; Singh N; Horn LC
    Int J Gynecol Cancer; 2022 Aug; 32(8):977-985. PubMed ID: 35764349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach.
    Yang H; Almadani N; Thompson EF; Tessier-Cloutier B; Chen J; Ho J; Senz J; McConechy MK; Chow C; Ta M; Cheng A; Karnezis A; Huvila J; McAlpine JN; Gilks B; Jamieson A; Hoang LN
    Mod Pathol; 2023 Jun; 36(6):100145. PubMed ID: 36828360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
    Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E
    Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma.
    Dongre HN; Elnour R; Tornaas S; Fromreide S; Thomsen LCV; Kolseth IBM; Nginamau ES; Johannessen AC; Vintermyr OK; Costea DE; Bjørge L
    Acta Obstet Gynecol Scand; 2024 Jan; 103(1):165-175. PubMed ID: 37840151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma.
    Proctor L; Hoang L; Moore J; Thompson E; Leung S; Natesan D; Chino J; Gilks B; McAlpine JN
    Int J Gynecol Cancer; 2020 Jan; 30(1):100-106. PubMed ID: 31771962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squamous Cell Carcinoma of the Vulva: A Subclassification of 97 Cases by Clinicopathologic, Immunohistochemical, and Molecular Features (p16, p53, and EGFR).
    Dong F; Kojiro S; Borger DR; Growdon WB; Oliva E
    Am J Surg Pathol; 2015 Aug; 39(8):1045-53. PubMed ID: 26171917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular events in the pathogenesis of vulvar squamous cell carcinoma.
    Xing D; Fadare O
    Semin Diagn Pathol; 2021 Jan; 38(1):50-61. PubMed ID: 33032902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva.
    Santos M; Montagut C; Mellado B; García A; Ramón y Cajal S; Cardesa A; Puig-Tintoré LM; Ordi J
    Int J Gynecol Pathol; 2004 Jul; 23(3):206-14. PubMed ID: 15213596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade vulvar intraepithelial neoplasia: comprehensive characterization and long-term vulvar carcinoma risk.
    Thuijs NB; van Beurden M; Duin S; Heideman DAM; Berkhof J; Steenbergen RDM; Bleeker MCG
    Histopathology; 2024 Jan; 84(2):301-314. PubMed ID: 37726173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV-independent Vulvar Squamous Cell Carcinoma is Associated With Significantly Worse Prognosis Compared With HPV-associated Tumors.
    Allo G; Yap ML; Cuartero J; Milosevic M; Ferguson S; Mackay H; Kamel-Reid S; Weinreb I; Ghazarian D; Pintilie M; Clarke BA
    Int J Gynecol Pathol; 2020 Jul; 39(4):391-399. PubMed ID: 31274700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus and p53 status define three types of vulvar squamous cell carcinomas with distinct clinical, pathological, and prognostic features.
    Carreras-Dieguez N; Saco A; Del Pino M; Marimon L; López Del Campo R; Manzotti C; Fusté P; Pumarola C; Torné A; Garcia A; Rakislova N
    Histopathology; 2023 Jul; 83(1):17-30. PubMed ID: 37099408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases.
    Cheng AS; Karnezis AN; Jordan S; Singh N; McAlpine JN; Gilks CB
    Int J Gynecol Pathol; 2016 Jul; 35(4):385-93. PubMed ID: 26630231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas.
    Santos M; Landolfi S; Olivella A; Lloveras B; Klaustermeier J; Suárez H; Alòs L; Puig-Tintoré LM; Campo E; Ordi J
    Am J Surg Pathol; 2006 Nov; 30(11):1347-56. PubMed ID: 17063073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of p53 and p16 Immunohistochemistry in the Classification of Human Papillomavirus-Associated, p53 Wild-Type, and p53 Abnormal Oral Epithelial Dysplasia.
    Novack R; Chapman E; Gao J; Horst B; Hoang LN; Ng TL; Ko YCK
    Mod Pathol; 2023 Dec; 36(12):100348. PubMed ID: 37820765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status.
    Tessier-Cloutier B; Kortekaas KE; Thompson E; Pors J; Chen J; Ho J; Prentice LM; McConechy MK; Chow C; Proctor L; McAlpine JN; Huntsman DG; Gilks CB; Bosse T; Hoang LN
    Mod Pathol; 2020 Aug; 33(8):1595-1605. PubMed ID: 32203095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulva.
    Parra-Herran C; Nucci MR; Singh N; Rakislova N; Howitt BE; Hoang L; Gilks CB; Bosse T; Watkins JC
    Mod Pathol; 2022 Oct; 35(10):1317-1326. PubMed ID: 35437330
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Lozar T; Keske A; Dube Mandishora RS; Yu Q; Bailey A; Xu J; Tommasino M; McGregor SM; Lambert PF; Gheit T; Fitzpatrick MB
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 Immunohistochemical patterns in HPV-related neoplasms of the female lower genital tract can be mistaken for TP53 null or missense mutational patterns.
    Thompson EF; Chen J; Huvila J; Pors J; Ren H; Ho J; Chow C; Ta M; Proctor L; McAlpine JN; Huntsman D; Gilks CB; Hoang L
    Mod Pathol; 2020 Sep; 33(9):1649-1659. PubMed ID: 32238876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
    van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of squamous cell cancers of the vulvar anterior fourchette by human papillomavirus, p16INK4a, and p53.
    Reuschenbach M; Roos J; Panayotopoulos D; Baldus SE; Schnürch HG; Berger A; Petry KU; Dürst M; Seiz M; von Knebel Doeberitz M; Hampl M;
    J Low Genit Tract Dis; 2013 Jul; 17(3):289-97. PubMed ID: 23645067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.